Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 5 Observational 2

Sponsor

Cancer Type

Conditions

Interventions

Blood Specimen Collection 135 Surveys and Questionnaires 132 Specimen Handling 57 Observation 55 Radiotherapy 43 Interviews as Topic 35 Surgical Procedures, Operative 31 Biopsy 30 Drug Therapy 30 Data Collection 25 Magnetic Resonance Spectroscopy 25 Nivolumab 21 Immune Checkpoint Inhibitors 18 Watchful Waiting 18 Standard of Care 17 Therapeutics 17 Immunotherapy 16 Magnetic Resonance Imaging 16 trastuzumab deruxtecan 14 Liquid Biopsy 13 Restraint, Physical 13 Tomography, X-Ray Computed 13 palbociclib 13 Radiosurgery 12 enzalutamide 12 Focus Groups 11 Hematologic Tests 11 apalutamide 11 darolutamide 11 pembrolizumab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

2 trials

Recent Start date Enrollment

Observational × vorasidenib × 1 year × Clear all

NCT07547163 2026-04-23

LGG PRO's

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Glioma

NCT07240662 2026-01-09

VIOLETA

iOMEDICO AG

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡